Los Angeles, California, United States Related Funds
| Fund Name | Location |
| Agri Investment Fund | Belgium, Leuven, Vlaams-Brabant |
| Blue Titan Ventures | Brooklyn, New York, United States |
| Bluesky Equities Ltd | Alberta, Calgary, Canada |
| C.V. Starr & Co | New York, New York, United States |
| China Create Capital Limited | China, Guangdong, Shenzhen |
| Forbes Family Trust | New York, New York, United States |
| LATINIA | Barcelona, Catalonia, Spain |
| Leeway Ventures | England, London, United Kingdom |
| Milestone Partners | Pennsylvania, Radnor, United States |
| Mingly Capital Corporation | China, Hong Kong, Hong Kong Island |
| Morgenthau Venture Partners | Florida, Fort Lauderdale, United States |
| New England Partners | Massachusetts, Quincy, United States |
| ResMed | California, San Diego, United States |
| Secret Escapes | England, London, United Kingdom |
| South African Government Employees Pension Fund | Gauteng, Pretoria, South Africa |
| Taylor Frigon | California, San Luis Obispo, United States |
| Thin Air Labs | Alberta, Calgary, Canada |
| Twin Ventures | California, San Francisco, United States |
| WEH Ventures | India, Maharashtra, Mumbai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lemonaid Health | $11M | 22 May 2017 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lemonaid Health | $11M | 22 May 2017 | San Francisco, California, United States |
